Atsushi Tsuruta Selected Research

Obstructive Jaundice (Cholestatic Jaundice)

1/2007

[Weekly paclitaxel therapy effective for gastric cancer with obstructive jaundice due to peritoneal dissemination--a case report].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Tsuruta Research Topics

Disease

9	Neoplasms (Cancer) 10/2020 - 02/2003
5	Stomach Neoplasms (Stomach Cancer) 10/2020 - 01/2007
3	Neoplasm Metastasis (Metastasis) 12/2019 - 09/2007
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2015
2	Rectal Neoplasms (Rectal Cancer) 01/2020 - 09/2017
2	Esophageal Neoplasms (Esophageal Cancer) 12/2019 - 06/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2009 - 07/2007
1	Hemolysis 02/2022
1	Lung Diseases (Lung Disease) 10/2020
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Microsatellite Instability 04/2020
1	Neuroendocrine Carcinoma 04/2020
1	Anorexia 03/2020
1	Lymphatic Metastasis 12/2019
1	Esophageal Squamous Cell Carcinoma 06/2019
1	Incisional Hernia 08/2014
1	Melanoma (Melanoma, Malignant) 06/2012
1	Breast Neoplasms (Breast Cancer) 09/2007
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2007
1	Ascites 01/2007
1	Genomic Instability 07/2006
1	Skin Neoplasms (Skin Cancer) 02/2003
1	Splenomegaly 02/2003
1	Carcinogenesis 02/2003

Drug/Important Bio-Agent (IBA)

2	Trastuzumab (Herceptin)FDA Link 12/2019 - 09/2007
2	Gemcitabine FDA Link 10/2009 - 07/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2007 - 01/2007
1	EsterasesIBA 02/2022
1	NivolumabIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	Calcibiotic Root Canal SealerIBA 04/2020
1	GTP Phosphohydrolases (GTPases)IBA 04/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2020
1	Carboplatin (JM8)FDA LinkGeneric 04/2020
1	MicroRNAs (MicroRNA)IBA 04/2020
1	S-1 plus cisplatinIBA 12/2019
1	stable plasma protein solutionIBA 09/2017
1	Capecitabine (Xeloda)FDA Link 01/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 11/2015
1	Polytetrafluoroethylene (Teflon)FDA Link 08/2014
1	CholesterolIBA 06/2012
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2012
1	Triethylenephosphoramide (TEPA)IBA 06/2012
1	Small Interfering RNA (siRNA)IBA 06/2012
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 06/2012
1	LuciferasesIBA 06/2012
1	Liposomes (Liposome)IBA 06/2012
1	cyclic arginine-glycine-aspartic acid peptideIBA 06/2012
1	Tumor Suppressor Protein p53IBA 07/2006
1	Phenobarbital (Luminal)FDA Link 02/2003
1	betaninIBA 02/2003
1	AcetoneIBA 02/2003
1	AntigensIBA 02/2003
1	Biological ProductsIBA 02/2003
1	CarcinogensIBA 02/2003
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 02/2003
1	caproamideIBA 02/2003
1	9,10-Dimethyl-1,2-benzanthraceneIBA 02/2003

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 10/2020 - 07/2007
4	Gastrectomy 10/2020 - 01/2007
2	Therapeutics 10/2020 - 01/2007
2	Neoadjuvant Therapy 01/2020 - 06/2019
1	Cholecystectomy 03/2020
1	Lymph Node Excision (Lymph Node Dissection) 03/2020
1	Chemoradiotherapy 06/2019
1	Decompression 01/2019
1	Self Expandable Metallic Stents 01/2019
1	Stents 01/2019
1	Induction Chemotherapy 12/2018
1	Proctectomy 09/2017
1	Adjuvant Chemotherapy 01/2016
1	Colectomy 05/2014
1	RNAi Therapeutics 06/2012
1	Intravenous Injections 06/2012
1	Oral Administration 02/2003
1	Topical Administration 02/2003
1	Chemoprevention 02/2003